4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-18-038884
Chief Financial Officer sold 20,000 shares at $14.01 ($280,200)
- Chief Financial Officer acquired 20,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Myszkowski Kenneth Allen · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-06-19 | Exercise or conversion : show line 1 in the form | +20,000 | $2.01 | $40,200 | 330,815 | D |
| 2018-06-19 | Sale : show line 2 in the form | −20,000 | $14.01 | $280,200 | 310,815 | D |
| Open-market sales · 20,000 sh · avg $14.01 · $280,200 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-06-19 | Exercise or conversion : show line 3 in the form Stock Option (right to buy) | −20,000 | 288,000 | D |
Loading xslF345X03/doc4.xml…